Europe Intra-Uterine Contraceptive Devices Market

September 2017 | 150 pages | ID: E128D12E99EEN
Data Bridge Market Research

Abstracts

In this region, Europe IUCD devices market is projected to reach USD 757.5 million by 2024, from USD 561.7 million in 2016 growing at a CAGR of 3.9% in the forecast period 2017 to 2024

Based on geography, the Europe IUCD devices market is segmented into 11 geographical regions, such as,

• Germany,
• France,
• United Kingdom,
• Italy,
• Spain,
• Russia,
• Turkey,
• Belgium,
• Netherlands,
• Switzerland and
• Rest Of Europe.

Europe IUCD devices market competition by top players including –

Bayer AG dominated the IUCD market accounting largest market share followed by Teva Pharmaceuticals Industries Ltd., and Mona Lisa N.V. along with others such as include

• DKT International,
• Egemen International,
• Melbea AG,
• Ocon Medical Ltd.,
• Pregna International Limited,
• Medical Engineering Corporation SA,
• SMB Corporation and Meril Life Sciences Pvt. Ltd.,
• Medu Scientific Ltd, China RH Contraceptives Co., Ltd,
• Sanghai Jolly Medical Education Co., Ltd,
• Bernstein Leibhard LLP,
• Zheijang Daji Medical Instruments, Ltd.,
• Nimble International,
• AME Line, Technico,
• Cepeo,
• Contraceptivos,
• Injeflex Ind And Com Ltda,
• Bersil,
• Amed.

The Europe intra-uterine contraceptive devices market is segmented on the basis of product type, end user, and geography.

The Europe intra-uterine contraceptive devices market is segmented into 2 product types, namely copper IUCD and hormonal IUCD.

On the basis of end users the market is segmented into hospitals, gynaecology clinics, and community healthcare. In 2017, the hospital segment is expected to dominate the market and is expected to continue this trend till 2024.

Contents

1. INTRODUCTION

1.1. OVERVIEW OF EUROPE INTRA-UTERINE CONTRACEPTIVE DEVICES (IUCD) MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED

2. MARKET SEGMENTATION

2.1. MARKETS COVERED
2.2. GEOGRAPHIC SCOPE
2.3. YEARS CONSIDERED FOR THE STUDY
2.4. CURRENCY AND PRICING
2.5. RESEARCH METHODOLOGY
2.6. PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.7. SECONDARY SOURCES
2.8. ASSUMPTIONS

3. MARKET OVERVIEW

3.1. DRIVERS
  3.1.1. INCREASED RATE OF UNPLANNED PREGNANCIES
  3.1.2. RISING NUMBER OF INITIATIVES UNDERTAKEN BY THE PRIVATE FIRMS
  3.1.3. FAVOURABLE INSURANCE FOR IUCD’S
  3.1.4. GROWING AWARENESS OF CONTRACEPTIVE
  3.1.5. GROWING FUNDS AND GRANTS FOR IUCD PRODUCTS
  3.1.6. TECHNOLOGICAL ADVANCEMENTS
3.2. RESTRAINTS
  3.2.1. HIGH COST OF TREATMENT
  3.2.2. THREAT OF CAUSING PELVIC INFLAMMOTORY DISEASE (PID)
  3.2.3. THREAT CAUSING EPICTAPIC PREGNANCY
  3.2.4. CHANGES IN GOVERNMENT REGULATIONS

4. EXECUTIVE SUMMARY

5. PREMIUM INSIGHTS

6. EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY PRODUCT TYPE

6.1. OVERVIEW

7. EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, BY GEOGRAPHY

7.1. OVERVIEW
7.2. EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.1. GERMANY INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.2. FRANCE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.3. ITALY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.4. U.K. INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.5. SWITZERLAND INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.6. NETHERLANDS INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.7. SPAIN INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.8. RUSSIA INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET
  7.2.9. BELGIUM INTRA-UTERINE CONTRACEPTIVE
(IUCD) DEVICES MARKET
  7.2.10. TURKEY INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET

8. EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET, COMPANY SHARE

8.1. COMPANY SHARE ANALYSIS: EUROPE
8.2. COMPANY SHARE ANALYSIS: NORTH AMERICA
8.3. COMPANY SHARE ANALYSIS: EUROPE
8.4. COMPANY SHARE ANALYSIS: ASIA PACIFIC
8.5. COMPANY SHARE ANALYSIS: SOUTH AMERICA
8.6. COMPANY SHARE ANALYSIS: MIDDLE EAST AND AFRICA

9. COMPANY PROFILES

9.1. BAYER AG
  9.1.1. COMPANY OVERVIEW
  9.1.2. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
  9.1.3. REVENUE ANALYSIS
  9.1.4. PRODUCT PORTFOLIO
  9.1.5. RECENT DEVELOPMENTS
  9.1.6. DATA BRIDGE ANALYSIS
9.2. TEVA PHARMACEUTICAL INDUSTRIES LTD.
  9.2.1. COMPANY OVERVIEW
  9.2.2. REVENUE ANALYSIS
  9.2.3. SWOT (STRENGTH, WEAKNESS, OPPORTUNITIES AND THREATS)
  9.2.4. PRODUCT PORTFOLIO
  9.2.5. RECENT DEVELOPMENTS
  9.2.6. DATA BRIDGE ANALYSIS
9.3. ALLERGEN PLC
  9.3.1. COMPANY OVERVIEW
  9.3.2. REVENUE ANALYSIS
  9.3.3. PRODUCT PORTFOLIO
  9.3.4. RECENT DEVELOPMENTS
  9.3.5. DATA BRIDGE ANALYSIS
9.4. DKT INTERNATIONAL
  9.4.1. COMPANY OVERVIEW
  9.4.2. REVENUE ANALYSIS
  9.4.3. PRODUCT PORTFOLIO
9.5. SMB CORPORATION
  9.5.1. COMPANY OVERVIEW
  9.5.2. REVENUE ANALYSIS
  9.5.3. PRODUCT PORTFOLIO
  9.5.4. RECENT DEVELOPMENTS
  9.5.5. DATA BRIDGE ANALYSIS
9.6. OCON MEDICAL LTD.
  9.6.1. COMPANY OVERVIEW
  9.6.2. REVENUE ANALYSIS
  9.6.3. PRODUCT PORTFOLIO
  9.6.4. RECENT DEVELOPMENTS
  9.6.5. DATA BRIDGE ANALYSIS
9.7. MONA LISA N.V.
  9.7.1. COMPANY OVERVIEW
  9.7.2. REVENUE ANALYSIS
  9.7.3. PRODUCT PORTFOLIO
  9.7.4. RECENT DEVELOPMENTS
9.8. MEDISAFE DISTRIBUTION INC.
  9.8.1. COMPANY OVERVIEW
  9.8.2. REVENUE ANALYSIS
  9.8.3. PRODUCT PORTFOLIO
  9.8.4. RECENT DEVELOPMENTS

10. RELATED REPORTS

TABLE LIST

TABLE 1 EUROPE IUCD DEVICES MARKET, BY COUNTRY, 2013 – 2024 (USD MILLION)
TABLE 2 EUROPEAN IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 3 EUROPE IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 4 EUROPE IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 5 GERMANY IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 6 GERMANY IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 7 GERMANY IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 8 FRANCE IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 9 FRANCE IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 10 FRANCE IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 11 ITALY IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 12 ITALY IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 13 ITALY IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 14 U.K. IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 15 U.K. IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 16 U.K. IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 17 SWITZERLAND IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 18 SWITZERLAND IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 19 SWITZERLAND IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 20 NETHERLANDS IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 21 NETHERLANDS IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 22 NETHERLANDS IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 23 SPAIN IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 24 SPAIN IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 25 SPAIN IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 26 RUSSIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 27 RUSSIA IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 28 RUSSIA IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 29 BELGIUM IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 30 BELGIUM IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 31 BELGIUM IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)
TABLE 32 TURKEY IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (USD MILLION)
TABLE 33 TURKEY IUCD DEVICES MARKET, BY PRODUCT TYPE, 2013 – 2024 (UNITS)
TABLE 34 TURKEY IUCD DEVICES MARKET, BY END USER, 2013 – 2024 (USD MILLION)

Figures

FIGURES LIST

FIGURE 1 EVOLUTION OF INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES
FIGURE 2 EUROPE INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: SEGMENTATION
FIGURE 3 EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: GEOGRAHIC SCOPE
FIGURE 4 EUROPE INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: DATA TRIANGULATION
FIGURE 5 EUROPE INTRA-UTERINE CONTRACEPTIVE DEVICES MARKET: SNAPSHOT
FIGURE 6 EUROPE IUCD DEVICES MARKET: BOTTOM UP APPROACH
FIGURE 7 EUROPE IUCD DEVICES MARKET: TOP DOWN APPROACH
FIGURE 8 EUROPE INTRA-UTERINE CONTRACEPTIVE (IUCD) DEVICES MARKET: INTERVIEWS BY REGION AND DESIGNATION
FIGURE 9 EUROPE IUCD DEVICES MARKET: COMPANY SHARE 2016 (%)

COMPNIES PROFILES

DKT International, Egemen International, Melbea AG, Ocon Medical Ltd., Pregna International Limited, Medical Engineering Corporation SA, SMB Corporation and Meril Life Sciences Pvt. Ltd., Medu Scientific Ltd, China RH Contraceptives Co., Ltd, Sanghai Jolly Medical Education Co., Ltd, Bernstein Leibhard LLP